158 POSTER Abiraterone acetate (AA), an irreversible inhibitor of CYP17, has significant and durable anti-tumor activity in both chemotherapy- naive and docetaxel treated castration-resistant prostate cancer (CRPC)

✍ Scribed by G. Attard; A. Reid; N. Babu Oommen; L. Folkerd; D. Olmos; E. Thompson; G. Maier; M. Dowsett; D. Dearnaley; J.S. De Bono

• Book ID: 119599313
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72090-1